References
- Cao B , LiXW, MaoY et al. Clinical features of the initial cases of 2009 pandemic influenza A (H1N1) virus infection in China. N. Engl. J. Med.361(26) , 2507–2517 (2009).
- Zarogoulidis P , KouliatsisG, PapanasN et al. Long-term respiratory follow-up of H1N1 infection. Virol. J.8 , 319 (2011).
- Zarogoulidis P , ConstantinidisT, SteiropoulosP, PapanasN, ZarogoulidisK, MaltezosE. Are there any differences in clinical and laboratory findings on admission between H1N1 positive and negative patients with flu-like symptoms?. BMC Res. Notes1(1) , 141 (2011).
- Maurer-Stroh S , LeeRT, EisenhaberF, CuiL, PhuahSP, LinRT. A new common mutation in the hemagglutinin of the 2009 (H1N1) influenza A virus. PLoS Curr.2 RRN1162 (2010).
- Strengell M , IkonenN, ZieglerT, JulkunenI. Minor changes in the hemagglutinin of influenza A(H1N1)2009 virus alter its antigenic properties. PLoS One6(10) , e25848 (2011).
- Hurt AC , DengYM, ErnestJ et al. Oseltamivir-resistant influenza viruses circulating during the first year of the influenza A(H1N1) 2009 pandemic in the Asia–Pacific region, March 2009 to March 2010. Euro. Surveill.16(3), pii: 19770 (2011).
- Svitek N , RuddPA, ObojesK, PilletS, von Messling V. Severe seasonal influenza in ferrets correlates with reduced interferon and increased IL-6 induction. Virology376(1) , 53–59 (2008).
- To KK , HungIF, LiIW et al. Delayed clearance of viral load and marked cytokine activation in severe cases of pandemic H1N1 2009 influenza virus infection. Clin. Infect. Dis.50(6) , 850–859 (2010).
- Lee N , ChanPK, WongCK et al. Viral clearance and inflammatory response patterns in adults hospitalized for pandemic 2009 influenza A(H1N1) virus pneumonia. Antivir. Ther.16(2) , 237–247 (2011).
- Fabbiani M , SaliM, Di Cristo V et al. Prospective evaluation of epidemiological, clinical, and microbiological features of pandemic influenza A (H1N1) virus infection in Italy. J. Med. Virol.83(12) , 2057–2065 (2011).
- Johnston SL , VirgoPF, UnsworthDJ. Type 1 diabetes mellitus masking primary antibody deficiency. J. Clin. Pathol.53(3) , 236–237 (2000).
- Hermaszewski RA , WebsterAD. Primary hypogammaglobulinaemia: a survey of clinical manifestations and complications. Q J Med.86(1) , 31–42 (1993).
- Zarogoulidis P , PapanasN, KioumisI, ChatzakiE, MaltezosE, ZarogoulidisK. Macrolides: from in vitro anti-inflammatory and immunomodulatory properties to clinical practice in respiratory diseases. Eur. J. Clin. Pharmacol.68(5) , 479–503 (2011).
- Yan B , YeS, ChenG, KuangM, ShenN, ChenS. Dysfunctional CD4+,CD25+ regulatory T cells in untreated active systemic lupus erythematosus secondary to interferon-alpha-producing antigen-presenting cells. Arthritis Rheum.58(3) , 801–812 (2008).
- Lacana E , AmurS, MummanneniP, ZhaoH, FruehFW. The emerging role of pharmacogenomics in biologics. Clin. Pharmacol. Ther.82(4) , 466–471 (2007).